Published in J Neurochem on December 01, 2005
Glutamatergic substrates of drug addiction and alcoholism. Biochem Pharmacol (2007) 3.06
Involvement of AMPA/kainate, NMDA, and mGlu5 receptors in the nucleus accumbens core in cue-induced reinstatement of cocaine seeking in rats. Psychopharmacology (Berl) (2007) 1.69
AMPA receptor synaptic plasticity induced by psychostimulants: the past, present, and therapeutic future. Neuron (2010) 1.68
Cocaine-induced neuroadaptations in glutamate transmission: potential therapeutic targets for craving and addiction. Ann N Y Acad Sci (2010) 1.64
NMDA receptors regulate nicotine-enhanced brain reward function and intravenous nicotine self-administration: role of the ventral tegmental area and central nucleus of the amygdala. Neuropsychopharmacology (2008) 1.57
Phosphorylation-dependent trafficking of GluR2-containing AMPA receptors in the nucleus accumbens plays a critical role in the reinstatement of cocaine seeking. J Neurosci (2008) 1.41
Signaling pathway adaptations and novel protein kinase A substrates related to behavioral sensitization to cocaine. J Neurochem (2009) 1.36
Synaptic plasticity in the mesolimbic system: therapeutic implications for substance abuse. Ann N Y Acad Sci (2010) 1.28
Extended daily access to cocaine results in distinct alterations in Homer 1b/c and NMDA receptor subunit expression within the medial prefrontal cortex. Synapse (2009) 1.27
microRNA-Seq reveals cocaine-regulated expression of striatal microRNAs. RNA (2011) 1.26
Cocaine-induced metaplasticity in the nucleus accumbens: silent synapse and beyond. Neuropharmacology (2011) 1.25
Glutamate and aspartate levels in the nucleus accumbens during cocaine self-administration and extinction: a time course microdialysis study. Psychopharmacology (Berl) (2007) 1.21
Gene profiling the response to repeated cocaine self-administration in dorsal striatum: a focus on circadian genes. Brain Res (2008) 1.09
Post-translational modification biology of glutamate receptors and drug addiction. Front Neuroanat (2011) 1.07
The encoding of cocaine vs. natural rewards in the striatum of nonhuman primates: categories with different activations. Neuroscience (2009) 1.01
Glutamate plasticity in the drunken amygdala: the making of an anxious synapse. Int Rev Neurobiol (2010) 0.99
De novo protein sequence analysis of Macaca mulatta. BMC Genomics (2007) 0.93
Cocainomics: new insights into the molecular basis of cocaine addiction. J Neuroimmune Pharmacol (2010) 0.92
Cytosolic proteomic alterations in the nucleus accumbens of cocaine overdose victims. Mol Psychiatry (2006) 0.91
Striatal signal transduction and drug addiction. Front Neuroanat (2011) 0.91
Ethanol self-administration modulation of NMDA receptor subunit and related synaptic protein mRNA expression in prefrontal cortical fields in cynomolgus monkeys. Brain Res (2010) 0.91
Assessment of genome and proteome profiles in cocaine abuse. Prog Brain Res (2006) 0.90
Continuous exposure to the competitive N-methyl-D: -aspartate receptor antagonist, LY235959, facilitates escalation of cocaine consumption in Sprague-Dawley rats. Psychopharmacology (Berl) (2007) 0.86
Integrative proteomic analysis of the nucleus accumbens in rhesus monkeys following cocaine self-administration. Mol Psychiatry (2008) 0.84
Dysbalance of cortical inhibition and excitation in abstinent cocaine-dependent patients. J Psychiatr Res (2011) 0.82
Cocaine-induced changes in NMDA receptor signaling. Mol Neurobiol (2014) 0.81
Relationship between development of cross-sensitization to MK-801 and delayed increases in glutamate levels in the nucleus accumbens induced by a high dose of methamphetamine. Psychopharmacology (Berl) (2006) 0.80
Dopaminergic dysregulation in prefrontal cortex of rhesus monkeys following cocaine self-administration. Front Psychiatry (2013) 0.78
Disrupting GluA2 phosphorylation potentiates reinstatement of cocaine seeking. Neuropharmacology (2016) 0.75
The glutamate receptor ion channels. Pharmacol Rev (1999) 15.06
Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons. Nature (2001) 5.65
Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior. J Neurosci (2003) 5.20
Expression of the transcription factor deltaFosB in the brain controls sensitivity to cocaine. Nature (1999) 4.29
Regulation of cocaine reward by CREB. Science (1998) 4.07
Unmanageable motivation in addiction: a pathology in prefrontal-accumbens glutamate transmission. Neuron (2005) 3.75
Phosphorylation of the AMPA receptor subunit GluR2 differentially regulates its interaction with PDZ domain-containing proteins. J Neurosci (2000) 3.44
Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction. J Neurosci (2000) 3.19
Altered responsiveness to cocaine and increased immobility in the forced swim test associated with elevated cAMP response element-binding protein expression in nucleus accumbens. J Neurosci (2001) 3.09
Limbic and motor circuitry underlying footshock-induced reinstatement of cocaine-seeking behavior. J Neurosci (2004) 2.87
Extinction-induced upregulation in AMPA receptors reduces cocaine-seeking behaviour. Nature (2003) 2.86
Neuroadaptations involved in amphetamine and cocaine addiction. Drug Alcohol Depend (1998) 2.71
Do rats have prefrontal cortex? The rose-woolsey-akert program reconsidered. J Cogn Neurosci (1995) 2.65
Regulation of immediate early gene expression and AP-1 binding in the rat nucleus accumbens by chronic cocaine. Proc Natl Acad Sci U S A (1992) 2.49
Widespread origin of the primate mesofrontal dopamine system. Cereb Cortex (1998) 2.43
FosB mutant mice: loss of chronic cocaine induction of Fos-related proteins and heightened sensitivity to cocaine's psychomotor and rewarding effects. Proc Natl Acad Sci U S A (1997) 1.98
Cocaine administered into the medial prefrontal cortex reinstates cocaine-seeking behavior by increasing AMPA receptor-mediated glutamate transmission in the nucleus accumbens. J Neurosci (2002) 1.94
Glutamate receptor subunit 2 Serine 880 phosphorylation modulates synaptic transmission and mediates plasticity in CA1 pyramidal cells. J Neurosci (2003) 1.90
Phosphorylation of serine-880 in GluR2 by protein kinase C prevents its C terminus from binding with glutamate receptor-interacting protein. J Neurochem (1999) 1.88
Repeated cocaine alters glutamate receptor subunit levels in the nucleus accumbens and ventral tegmental area of rats that develop behavioral sensitization. J Neurochem (1999) 1.86
A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res (1991) 1.84
Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents. J Neurosci (1996) 1.80
A role for nucleus accumbens glutamate transmission in the relapse to cocaine-seeking behavior. Neuroscience (1999) 1.80
Molecular neuroadaptations in the accumbens and ventral tegmental area during the first 90 days of forced abstinence from cocaine self-administration in rats. J Neurochem (2003) 1.72
Involvement of cAMP-dependent protein kinase in the nucleus accumbens in cocaine self-administration and relapse of cocaine-seeking behavior. J Neurosci (1998) 1.70
The synaptic framework for chemical signaling in nucleus accumbens. Ann N Y Acad Sci (1999) 1.63
Increased responsiveness of ventral tegmental area dopamine neurons to glutamate after repeated administration of cocaine or amphetamine is transient and selectively involves AMPA receptors. J Pharmacol Exp Ther (1997) 1.61
Repeated administration of amphetamine or cocaine does not alter AMPA receptor subunit expression in the rat midbrain. Neuropsychopharmacology (2002) 1.61
Pharmacological studies of the regulation of chronic FOS-related antigen induction by cocaine in the striatum and nucleus accumbens. J Pharmacol Exp Ther (1995) 1.60
Repeated administration of cocaine or amphetamine alters neuronal responses to glutamate in the mesoaccumbens dopamine system. J Pharmacol Exp Ther (1995) 1.54
Common neural substrates for the addictive properties of nicotine and cocaine. Science (1997) 1.47
Fatal excited delirium following cocaine use: epidemiologic findings provide new evidence for mechanisms of cocaine toxicity. J Forensic Sci (1997) 1.43
Molecular profiling of midbrain dopamine regions in cocaine overdose victims. J Neurochem (2003) 1.42
The organization of midbrain projections to the ventral striatum in the primate. Neuroscience (1994) 1.37
Chronic cocaine treatment decreases levels of the G protein subunits Gi alpha and Go alpha in discrete regions of rat brain. J Neurochem (1990) 1.32
Glutamate transmission and addiction to cocaine. Ann N Y Acad Sci (2003) 1.25
Effects of dopamine transporter inhibitors on cocaine self-administration in rhesus monkeys: relationship to transporter occupancy determined by positron emission tomography neuroimaging. J Pharmacol Exp Ther (2004) 1.24
Regulation of excitatory and inhibitory neurotransmitter-gated ion channels by protein phosphorylation. Curr Opin Neurobiol (1997) 1.21
Organization of corticocortical connections in human visual cortex. Proc Natl Acad Sci U S A (1989) 1.11
Reinstatement and spontaneous recovery of cocaine-seeking following extinction and different durations of withdrawal. Behav Pharmacol (2002) 1.10
Cocaine sensitization and craving: differing roles for dopamine and glutamate in the nucleus accumbens. J Addict Dis (2001) 1.10
Arterial hypertension in the squirrel monkey during behavioral experiments. Am J Physiol (1969) 1.10
Differential behavioral responses to cocaine are associated with dynamics of mesolimbic dopamine proteins in Lewis and Fischer 344 rats. Synapse (2001) 1.07
Behavioral sensitization to cocaine: modulation by the cyclic AMP system in the nucleus accumbens. Brain Res (1995) 1.03
Repeated cocaine administration alters the expression of genes in corticolimbic circuitry after a 3-week withdrawal: a DNA macroarray study. J Neurochem (2002) 1.03
Glutamate receptor subtype expression in human postmortem brain tissue from schizophrenics and alcohol abusers. Brain Res (1995) 1.03
Neuroadaptations in ionotropic and metabotropic glutamate receptor mRNA produced by cocaine treatment. J Neurochem (1999) 1.01
The behavioral effects of cocaine: rate dependency or rate constancy. Eur J Pharmacol (1979) 1.01
Analysis of cocaine and metabolites in brain using solid phase extraction and full-scanning gas chromatography/ion trap mass spectrometry. Forensic Sci Int (1994) 1.01
Altered expression and phosphorylation of N-methyl-D-aspartate receptors in piglet striatum after hypoxia-ischemia. Brain Res Mol Brain Res (2002) 0.98
Localization of ionotropic glutamate receptors in caudate-putamen and nucleus accumbens septi of rat brain: comparison of NMDA, AMPA, and kainate receptors. Synapse (1998) 0.91
Neuroadaptive changes in NMDAR1 gene expression after extinction of cocaine self-administration. Ann N Y Acad Sci (2002) 0.90
Distinct presynaptic regulation of dopamine release through NMDA receptors in striosome- and matrix-enriched areas of the rat striatum. J Neurosci (1991) 0.89
Correlation between behavioral sensitization to cocaine and G protein ADP-ribosylation in the ventral tegmental area. Brain Res (1992) 0.86
The striatal mosaic in primates: striosomes and matrix are differentially enriched in ionotropic glutamate receptor subunits. J Neurosci (1993) 0.85
Locomotor activation induced by MK-801 in the rat: postsynaptic interactions with dopamine receptors in the ventral striatum. Eur J Pharmacol (1994) 0.84
Expression of N-methyl-D-aspartate receptor subunit mRNAs in the human brain: striatum and globus pallidus. J Comp Neurol (1998) 0.84
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. Arch Neurol (2003) 3.47
A genomic pathway approach to a complex disease: axon guidance and Parkinson disease. PLoS Genet (2007) 3.28
Genetic variation in human NPY expression affects stress response and emotion. Nature (2008) 2.65
Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08
Lrrk2 and Lewy body disease. Ann Neurol (2006) 2.00
Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brain. Neuropharmacology (2003) 1.70
National Association of Medical Examiners position paper on the certification of cocaine-related deaths. Am J Forensic Med Pathol (2004) 1.65
Clinical heterogeneity of the LRRK2 G2019S mutation. Arch Neurol (2006) 1.63
(18)F-FECNT: validation as PET dopamine transporter ligand in parkinsonism. Exp Neurol (2010) 1.61
Cochlear gap junctions coassembled from Cx26 and 30 show faster intercellular Ca2+ signaling than homomeric counterparts. Am J Physiol Cell Physiol (2005) 1.49
Restoration of connexin26 protein level in the cochlea completely rescues hearing in a mouse model of human connexin30-linked deafness. Proc Natl Acad Sci U S A (2007) 1.44
Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease. Neurobiol Aging (2006) 1.43
On blacklisting in science. Sci Eng Ethics (2008) 1.43
Characterization of the cocaine- and amphetamine-regulated transcript (CART) peptide gene promoter and its activation by a cyclic AMP-dependent signaling pathway in GH3 cells. J Neurochem (2002) 1.43
Applications of targeted gene capture and next-generation sequencing technologies in studies of human deafness and other genetic disabilities. Hear Res (2012) 1.43
Molecular profiling of midbrain dopamine regions in cocaine overdose victims. J Neurochem (2003) 1.42
Gap junction-mediated intercellular biochemical coupling in cochlear supporting cells is required for normal cochlear functions. Proc Natl Acad Sci U S A (2005) 1.39
Substance-specific and shared transcription and epigenetic changes in the human hippocampus chronically exposed to cocaine and alcohol. Proc Natl Acad Sci U S A (2011) 1.38
Cyanobacterial Blooms and the Occurrence of the neurotoxin beta-N-methylamino-L-alanine (BMAA) in South Florida Aquatic Food Webs. Harmful Algae (2010) 1.36
Determinants of buildup of the toxic dopamine metabolite DOPAL in Parkinson's disease. J Neurochem (2013) 1.34
Targeted connexin26 ablation arrests postnatal development of the organ of Corti. Biochem Biophys Res Commun (2009) 1.32
Intronic polymorphisms affecting alternative splicing of human dopamine D2 receptor are associated with cocaine abuse. Neuropsychopharmacology (2010) 1.29
Cocaine- and amphetamine-related transcript is involved in the orexigenic effect of endogenous anandamide. Neuroendocrinology (2005) 1.26
Connexin30 null and conditional connexin26 null mice display distinct pattern and time course of cellular degeneration in the cochlea. J Comp Neurol (2009) 1.25
Glucosidase-beta variations and Lewy body disorders. Parkinsonism Relat Disord (2008) 1.24
Nicotinic α5 receptor subunit mRNA expression is associated with distant 5' upstream polymorphisms. Eur J Hum Genet (2010) 1.23
Multiregional gene expression profiling identifies MRPS6 as a possible candidate gene for Parkinson's disease. Gene Expr (2006) 1.21
Diverse deafness mechanisms of connexin mutations revealed by studies using in vitro approaches and mouse models. Brain Res (2009) 1.20
Intra-accumbal injection of CART (cocaine-amphetamine regulated transcript) peptide reduces cocaine-induced locomotor activity. J Pharmacol Exp Ther (2003) 1.20
Gap junction mediated intercellular metabolite transfer in the cochlea is compromised in connexin30 null mice. PLoS One (2008) 1.16
Differential regulation of ionotropic glutamate receptor subunits following cocaine self-administration. Brain Res (2005) 1.14
CART regulates islet hormone secretion and is expressed in the beta-cells of type 2 diabetic rats. Diabetes (2006) 1.13
GABAergic gene expression in postmortem hippocampus from alcoholics and cocaine addicts; corresponding findings in alcohol-naïve P and NP rats. PLoS One (2012) 1.12
Synthesis, monoamine transporter binding properties, and behavioral pharmacology of a series of 3beta-(substituted phenyl)-2beta-(3'-substituted isoxazol-5-yl)tropanes. J Med Chem (2004) 1.12
Development of the dopamine transporter selective RTI-336 as a pharmacotherapy for cocaine abuse. AAPS J (2006) 1.12
Increased metabolism in the R6/2 mouse model of Huntington's disease. Neurobiol Dis (2007) 1.11
Cyanobacterial neurotoxin β-N-methylamino-L-alanine (BMAA) in shark fins. Mar Drugs (2012) 1.10
An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology. J Neurol Neurosurg Psychiatry (2012) 1.09
Cocaine- and amphetamine-regulated transcript peptide projections in the ventral midbrain: colocalization with gamma-aminobutyric acid, melanin-concentrating hormone, dynorphin, and synaptic interactions with dopamine neurons. J Comp Neurol (2002) 1.09
Quantitative PCR-based screening of alpha-synuclein multiplication in multiple system atrophy. Parkinsonism Relat Disord (2007) 1.08
Digenic inheritance of non-syndromic deafness caused by mutations at the gap junction proteins Cx26 and Cx31. Hum Genet (2008) 1.08
The effects of cocaine on CART expression in the rat nucleus accumbens: a possible role for corticosterone. Eur J Pharmacol (2005) 1.06
ATP13A2 variability in Parkinson disease. Hum Mutat (2009) 1.05
Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases. Amyotroph Lateral Scler (2009) 1.05
Common human 5' dopamine transporter (SLC6A3) haplotypes yield varying expression levels in vivo. Cell Mol Neurobiol (2006) 1.05
Somatic mtDNA mutation spectra in the aging human putamen. PLoS Genet (2013) 1.04
Criteria for the interpretation of cocaine levels in human biological samples and their relation to the cause of death. Am J Forensic Med Pathol (2004) 1.03
MDMA self-administration in rats: acquisition, progressive ratio responding and serotonin transporter binding. Eur J Neurosci (2007) 1.03
Monoamine transporter binding, locomotor activity, and drug discrimination properties of 3-(4-substituted-phenyl)tropane-2-carboxylic acid methyl ester isomers. J Med Chem (2004) 1.02
Identifying consensus disease pathways in Parkinson's disease using an integrative systems biology approach. PLoS One (2011) 1.02
Regulation of CART mRNA in the rat nucleus accumbens via D3 dopamine receptors. Neuropharmacology (2006) 1.02
Blacklisting among scientists. Synapse (2009) 1.01
Injection of CART (cocaine- and amphetamine-regulated transcript) peptide into the nucleus accumbens reduces cocaine self-administration in rats. Behav Brain Res (2008) 1.01
Response of rats to low levels of sarin. Toxicol Appl Pharmacol (2002) 1.01
Glucocerebrosidase mutations in diffuse Lewy body disease. Parkinsonism Relat Disord (2011) 1.00
Ethanol-induced regulation of GABA-A subunit mRNAs in prefrontal fields of cynomolgus monkeys. Alcohol Clin Exp Res (2006) 1.00
Effects of dopamine transporter selective 3-phenyltropane analogs on locomotor activity, drug discrimination, and cocaine self-administration after oral administration. Eur J Pharmacol (2006) 0.99
Deoxygedunin, a natural product with potent neurotrophic activity in mice. PLoS One (2010) 0.99
Decreased expression of the transcription factor NURR1 in dopamine neurons of cocaine abusers. Proc Natl Acad Sci U S A (2002) 0.99
Prevalent polymorphism in thyroid hormone-activating enzyme leaves a genetic fingerprint that underlies associated clinical syndromes. J Clin Endocrinol Metab (2015) 0.98
Regional and cellular expression of CYP2D6 in human brain: higher levels in alcoholics. J Neurochem (2002) 0.97
Cocaine- and amphetamine-regulated transcript (CART) peptide activates the extracellular signal-regulated kinase (ERK) pathway in AtT20 cells via putative G-protein coupled receptors. Neurosci Lett (2005) 0.97
Cocaine-amphetamine-regulated transcript expression in the rat nucleus accumbens is regulated by adenylyl cyclase and the cyclic adenosine 5'-monophosphate/protein kinase a second messenger system. J Pharmacol Exp Ther (2005) 0.96
The rhesus macaque is three times as diverse but more closely equivalent in damaging coding variation as compared to the human. BMC Genet (2012) 0.94
CART peptides as modulators of dopamine and psychostimulants and interactions with the mesolimbic dopaminergic system. Biochem Pharmacol (2007) 0.94
Intra-VTA CART 55-102 reduces the locomotor effect of systemic cocaine in rats: an isobolographic analysis. Neuropeptides (2007) 0.94
Cocaine and amphetamine regulated transcript (CART) and the stress response. Peptides (2006) 0.94
Correlating human and animal studies of cocaine abuse and gene expression. Ann N Y Acad Sci (2008) 0.94
Differential expression of human COMT alleles in brain and lymphoblasts detected by RT-coupled 5' nuclease assay. Psychopharmacology (Berl) (2004) 0.94
Excited Delirium Syndrome (ExDS): defining based on a review of the literature. J Emerg Med (2011) 0.93
Transcriptional regulation of the CART promoter in CATH.a cells. Brain Res Mol Brain Res (2004) 0.93
Synthesis and in vivo evaluation of fluorine-18 and iodine-123 labeled 2beta-carbo(2-fluoroethoxy)-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane as a candidate serotonin transporter imaging agent. J Med Chem (2007) 0.93
Phenotypic associations of tau and ApoE in Parkinson's disease. Neurosci Lett (2007) 0.93
Maternal separation and handling affects cocaine self-administration in both the treated pups as adults and the dams. J Pharmacol Exp Ther (2006) 0.93
Cause, seasonality of death and co-morbidities in progressive supranuclear palsy (PSP). Parkinsonism Relat Disord (2005) 0.93
The cochlear pericytes. Microcirculation (2008) 0.93
The neuroprotective enzyme CYP2D6 increases in the brain with age and is lower in Parkinson's disease patients. Neurobiol Aging (2011) 0.93
Cerebral uptake and protein incorporation of cyanobacterial toxin β-N-methylamino-L-alanine. Neuroreport (2013) 0.91
Cocaine abuse elevates alpha-synuclein and dopamine transporter levels in the human striatum. Neuroreport (2005) 0.91
CART peptides as targets for CNS drug development. Curr Drug Targets CNS Neurol Disord (2003) 0.91
CART peptide stimulation of G protein-mediated signaling in differentiated PC12 cells: identification of PACAP 6-38 as a CART receptor antagonist. Neuropeptides (2011) 0.91
Markers for dopaminergic neurotransmission in the cerebellum in normal individuals and patients with Parkinson's disease examined by RT-PCR. Eur J Neurosci (2003) 0.91
Synthesis and monoamine transporter binding properties of 2,3-diaryltropanes. J Med Chem (2005) 0.91
CART in feeding and obesity. Trends Endocrinol Metab (2004) 0.91
Colocalization of CART peptide with prodynorphin and dopamine D1 receptors in the rat nucleus accumbens. Neuropeptides (2006) 0.91
Induction of the drug metabolizing enzyme CYP2D in monkey brain by chronic nicotine treatment. Neuropharmacology (2008) 0.90
Cortical and amygdalar Lewy body burden in Parkinson's disease patients with visual hallucinations. Parkinsonism Relat Disord (2005) 0.90
CART (cocaine- and amphetamine-regulated transcript) peptide receptors: specific binding in AtT20 cells. Eur J Pharmacol (2005) 0.88
Cocaine- and amphetamine-regulated transcript peptide in the rat anterior pituitary gland is localized in gonadotrophs and suppresses prolactin secretion. Endocrinology (2004) 0.88
Withdrawal from repeated cocaine alters dopamine transporter protein turnover in the rat striatum. J Pharmacol Exp Ther (2003) 0.87
The Leu34Phe ProCART mutation leads to cocaine- and amphetamine-regulated transcript (CART) deficiency: a possible cause for obesity in humans. Endocrinology (2005) 0.86
Sex differences in the regulation of cocaine and amphetamine-regulated transcript expression in hypothalamic nuclei of rats by forced swim stress. Synapse (2007) 0.86
CART receptor binding in primary cell cultures of the rat nucleus accumbens. Synapse (2008) 0.86
Effects of resveratrol on acoustic trauma. Otolaryngol Head Neck Surg (2003) 0.86
The natural non-protein amino acid N-β-methylamino-L-alanine (BMAA) is incorporated into protein during synthesis. Amino Acids (2014) 0.85
BisQC: an operational pipeline for multiplexed bisulfite sequencing. BMC Genomics (2014) 0.85
CART peptide diurnal rhythm in brain and effect of fasting. Brain Res (2005) 0.85